Biotech companies by P/S ratio

Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.

CG Oncology leads the 19 biotech companies ranked by P/S ratio, at 1769, ahead of CRISPR Therapeutics (1111) and Kymera Therapeutics (264). Figures as of 18 Nov 2026, 23:52 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
19
First
CG Oncology1769
Median
14.3
Combined market value
£636.2B
Countries
5
Not ranked
5no P/S ratio on file

Market values as of .

All countries
All sectors
Biotech
GBP
Clear filters
Biotech companies by P/S ratio
#CompanyP/S ↓Market capPriceToday1 yearPrice, 30 daysCountry
1CG OncologyCGON · Health Care1769£5.4B£60.85 1.34% up 85% up United States
2CRISPR TherapeuticsCRSP · Health Care1111£3B£30.57 0.10% up 21% down Switzerland
3Kymera TherapeuticsKYMR · Health Care264£7.9B£92.13 0.32% down 87% up United States
4ImmunityBioIBRX · Health Care62.9£5.4B£5.10 7.03% up 193% up United States
5ModernaMRNA · Health Care41.0£60.6B£149.68 4.84% down 755% up United States
6Krystal BiotechKRYS · Health Care24.0£7.1B£239.85 5.62% up 46% up United States
7Twist BioscienceTWST · Health Care21.1£6B£88.50 3.88% up 340% up United States
8Adaptive BiotechnologiesADPT · Health Care16.6£3.5B£21.65 0.11% down 88% up United States
9RepligenRGEN · Health Care15.0£8.4B£131.33 6.47% up 5% up United States
10argenxARGX · Health Care14.3£45B£715.92 0.66% down 4% up Belgium
11Bio-TechneTECH · Health Care9.4£8.7B£55.33 0.17% up 26% up United States
12Halozyme TherapeuticsHALO · Health Care7.8£8.3B£72.87 0.18% down 37% up United States
13ExelixisEXEL · Health Care7.2£12.7B£51.94 0.31% down 63% up United States
14Gilead SciencesGILD · Health Care7.1£159.4B£128.53 0.75% down 33% up United States
15AmgenAMGN · Health Care6.5£182.6B£337.63 3.07% down 34% up United States
16BioNTechBNTX · Health Care6.5£15.7B£63.33 1.89% down 16% down Germany
17Neurocrine BiosciencesNBIX · Health Care5.8£12.5B£123.87 1.84% down 20% up United States
18QiagenQGEN · Health Care4.9£7.8B£37.70 0.38% down 12% up Netherlands
19BiogenBIIB · Health Care3.8£28.3B£191.22 0.25% up 49% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. P/S divides today's market value by the latest fiscal year's revenue from the annual report. Sums are converted from US dollars at today's exchange rate (1 USD = 0.7606 GBP). 5 companies have no P/S ratio on file and are not ranked here.

Questions and answers

Which biotech companies rank first by P/S ratio?

CG Oncology (1769), CRISPR Therapeutics (1111) and Kymera Therapeutics (264) are the top three of the 19 biotech companies ranked by P/S ratio as of 18 Nov 2026, 23:52 UTC.

How many biotech companies are in this ranking?

19 are ranked by P/S ratio. 5 more have no P/S ratio on file and are left out rather than ranked at zero.

What are these biotech companies worth together?

The 19 biotech companies ranked by P/S ratio have a combined market value of £636.2B as of 18 Nov 2026, 23:52 UTC.

What does ranking by P/S ratio measure?

Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.

Cite this page

Funkfolio, “Biotech companies by P/S ratio”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=ps-ratio

Underlying data: Yahoo Finance; SEC EDGAR.